fda glp-1 compounding crackdown september 2025 BREAKING NEWS in the space 🚨 is at it again saying they're going to take action limiting access to the active ingredients used to make the compounded medications. Watch September 2, 2025: U.S. compounding

At Idea Usher, our Hybrid Structure allows your business to rapidly scale your engineering capacity using our global developers while keeping your core database security under domestic oversight

Ichijo H, Nshida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y

By Drug Type: Prescription Dominance Reinforced by Payer Mandates Prescription products represented 64.53% of the anti-obesity drugs market in 2025, and the cohort is on track for a 32.85% CAGR through 2031

Metabolic health, cardiovascular resilience, cognitive function, and long-term protection against neurodegeneration are all plausibly within reach of a therapeutic strategy that addresses both the hormonal and metabolic dimensions of the menopausal transition simultaneously